Lumaka Aimé, Lubala Toni Kasole, Race Valérie, Peeters Hilde, Lukusa Prosper, Devriendt Koenraad
Centre for Human Genetics, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Laboratory of Human Genetics, GIGA-Institute, University of Liège, 4500, Liège, Belgium.
J Community Genet. 2019 Jan;10(1):153-159. doi: 10.1007/s12687-018-0374-4. Epub 2018 Jul 4.
Screening for fragile X syndrome (FXS) is essential in children with developmental delay or intellectual disability (ID). In addition, using clinical screening checklists remains of high interest in resource-limited settings. We aimed to gain insight into the prevalence of FXS and the distribution of CGG alleles and to evaluate the usefulness of three checklists in specialized institutions in Kinshasa, DR Congo. We recruited 80 males and 25 females from six specialized institutions in Kinshasa and administered a questionnaire comprising items from the following FXS checklists: Hagerman, Maes, and Guruju. FMR1 CGG repeats were assessed for every patient. About 37% of patients were referable for FX testing based on Hagerman's checklist, 35% for Maes', and 43.80% for Guruju's, but none of them was molecularly confirmed to have FXS. Thus, specificities were 62.86, 64.76, and 56.5%, respectively, for Hagerman, Maes, and Guruju, respectively. The mean CGG allele size was 28.55 ± 2.83 (ranges, 17-48). The 29 CGG was the most frequent allele (24.61%). Thus, existing checklists should not be automatically applied to Congolese patients without adjustments. The distribution of CGG repeats and the number of CGG alleles are similar to other African studies.
对发育迟缓或智力残疾(ID)儿童进行脆性X综合征(FXS)筛查至关重要。此外,在资源有限的环境中,使用临床筛查清单仍然备受关注。我们旨在深入了解FXS的患病率和CGG等位基因的分布情况,并评估刚果民主共和国金沙萨的三家专门机构中三份清单的实用性。我们从金沙萨的六家专门机构招募了80名男性和25名女性,并发放了一份问卷,其中包含来自以下FXS清单的项目:哈格曼清单、梅斯清单和古鲁朱清单。对每位患者的FMR1 CGG重复序列进行了评估。根据哈格曼清单,约37%的患者可转诊进行FX检测;根据梅斯清单,这一比例为35%;根据古鲁朱清单,这一比例为43.80%,但他们均未通过分子检测确诊为FXS。因此,哈格曼、梅斯和古鲁朱清单的特异性分别为62.86%、64.76%和56.5%。CGG等位基因的平均大小为28.55 ± 2.83(范围为17 - 48)。29个CGG是最常见的等位基因(24.61%)。因此,在未经调整的情况下,现有清单不应自动应用于刚果患者。CGG重复序列的分布和CGG等位基因的数量与其他非洲研究相似。